Enterprise strategy 2024 — today
Scientific intelligence, measured by decisions
Defined the enterprise product strategy that moved R&D AI evaluation off usage dashboards and onto research impact, decision quality, and value. The decision framework it produced now guides AI investment, platform, and vendor priorities.
Product visionRoadmapAI governanceValue measurement
Translational AI 2023 — 2026
Rare disease borrows from common biology
Built a translational strategy that used shared mechanism to work around sparse rare-disease data, integrating biological, clinical, and real-world evidence. Applied across seven assets to prioritize repurposing and indication expansion.
Dis2VecKnowledge graphsIndication strategy
Evaluation 2023 — today
Benchmark-first, or it does not ship
Grounded model and vendor assessment in biological evidence and real clinical-trial decisions rather than leaderboard scores — five vendors evaluated, two academic partnerships established, including Orphanet and the European Reference Networks.
BenchmarkingVendor strategyGeneralizability